Evidence map›Paper›PMID 35022236›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Reevaluation of the role of LIP-1 as an ERK/MPK-1 dual specificity phosphatase in the

Debabrata Das, Jacob Seemann, David Greenstein, Tim Schedl, Swathi Arur

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Debabrata DasDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-5472-6363
Jacob SeemannDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-5113-9788
David GreensteinDepartment of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0001-8189-2087
Tim SchedlDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-2148-2996
Swathi ArurDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030; sarur@mdanderson.org.ORCID 0000-0002-6941-2711
The University of Texas MD Anderson Cancer Center · USUniversity of Minnesota · USWashington University in St. Louis · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
CONTROL OF MEIOSIS AND GERMLINE PROLIFERATIONR01GM057173 · NIGMS · VANDERBILT UNIVERSITY · PI GREENSTEIN, DAVID IRWIN · 1998 to 2021
$6.6M
Stem cell versus meiotic fate decision in C. elegansR01GM100756 · NIGMS · WASHINGTON UNIVERSITY · PI SCHEDL, TIM · 2012 to 2023
$4.2M
Erk-mediated regulation of Dicer and Drosha function in C. elegansR01GM098200 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ARUR, SWATHI · 2011 to 2020
$3.3M
The C. elegans Germline: A Test Tube for Cell and Developmental BiologyR35GM144029 · NIGMS · UNIVERSITY OF MINNESOTA · PI David Irwin Greenstein · 2022 to 2026
$2.1M
ERK mediated regulation of RbAp46/48 during female germ cell developmentR01HD101269 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ARUR, SWATHI · 2020 to 2024
$1.6M
Control of Meiosis and Germline ProliferationR56GM057173 · NIGMS · UNIVERSITY OF MINNESOTA · PI GREENSTEIN, DAVID IRWIN · 2008 to 2008
$310k
NCI NIH HHS P30 CA016672NICHD NIH HHS R01 HD101269NIGMS NIH HHS R01 GM057173NIGMS NIH HHS R01 GM098200NIGMS NIH HHS R01 GM100756NIGMS NIH HHS R35 GM144029NIGMS NIH HHS R56 GM057173NIH HHS P40 OD010440
6 · The paper itself

Abstract

The fidelity of a signaling pathway depends on its tight regulation in space and time. Extracellular signal-regulated kinase (ERK) controls wide-ranging cellular processes to promote organismal development and tissue homeostasis. ERK activation depends on a reversible dual phosphorylation on the TEY motif in its active site by ERK kinase (MEK) and dephosphorylation by DUSPs (dual specificity phosphatases). LIP-1, a DUSP6/7 homolog, was proposed to function as an ERK (MPK-1) DUSP in the

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell Cycle ProteinsCell ProliferationEnzyme ActivationGerm CellsMitogen-Activated Protein Kinase 1MutationOocytesPachytene StagePhenotypePhosphorylationProtein Tyrosine PhosphatasesSubstrate SpecificitySynaptonemal ComplexCaenorhabditis elegans ProteinsCell Cycle Proteinslip-1 protein, C elegansMitogen-Activated Protein Kinase 1mpk-1 protein, C elegansProtein Tyrosine PhosphatasesC. elegansgermlineLIP-1 DUSPMPK-1 ERK

Identifiers

PMID35022236
PMCPMC8784128
OpenAlexW4205224517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.